Quick Takeaways
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G/A for Rocket Pharmaceuticals, Inc. Common Stock (RCKT).
- Disclosed ownership: 0.9%.
- Date of event: 30 May 2025.
WELLINGTON MANAGEMENT GROUP LLP - 30 May 2025 SCHEDULE 13G/A Report for Rocket Pharmaceuticals, Inc. Common Stock (RCKT)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Symbol
- RCKT
- Shares outstanding
- 111,608,444 shares
- Disclosed Ownership
- 1,004,476 shares
- Ownership
- 0.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Jun 2025, 19:43:39 UTC
- Date of event
- 30 May 2025
- Previous filing
- 07 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WELLINGTON MANAGEMENT GROUP LLP disclosed 0.9% ownership in Rocket Pharmaceuticals, Inc. Common Stock (RCKT) on 30 May 2025."
What Changed
- Previous schedule filing date: 07 May 2025.
- Current filing was accepted on 05 Jun 2025, 19:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 0.9% | 1,004,476 | 0 | 770,285 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 0.9% | 1,004,476 | 0 | 770,285 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 0.9% | 1,004,476 | 0 | 770,285 | Taisia Lowe | Regulatory Analyst |